Impact of radiotherapy dose, fractionation and immunotherapeutic partner in a mouse model of HR+ mammary carcinogenesis.
Buqué A, Bloy N, Petroni G, Jiménez-Cortegana C, Sato A, Iribarren C, Yamazaki T, Galassi C, Hensler M, Bhinder B, Guarracino A, Rippon B, Beltran-Visiedo M, Soler-Agesta R, Pannellini T, Fucikova J, Demaria S, Zhou XK, Elemento O, Formenti SC, Galluzzi L.
Buqué A, et al. Among authors: galluzzi l.
J Natl Cancer Inst. 2024 Dec 11:djae329. doi: 10.1093/jnci/djae329. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 39661487